UNITED THERAPEUTICS CORP (UTHR)
US91307C1027 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to UTHR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 298.1. This target is 27.47% above the current price.
UTHR was analyzed by 22 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about UTHR.
In the previous month the buy percentage consensus was at a similar level.
UTHR was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-12 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2024-02-05 | Leerink Partners | Initiate | Outperform |
| 2023-11-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-11-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-03 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-08-03 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-04 | Ladenburg Thalmann | Maintains | Buy |
| 2023-04-21 | Argus Research | Maintains | Buy |
| 2023-04-10 | UBS | Maintains | Buy |
| 2023-04-10 | Morgan Stanley | Maintains | Overweight |
| 2023-02-23 | JP Morgan | Maintains | Overweight |
| 2023-02-23 | Morgan Stanley | Maintains | Overweight |
| 2023-02-23 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-11 | Argus Research | Maintains | Buy |
| 2022-12-06 | UBS | Initiate | Buy |
| 2022-12-06 | Morgan Stanley | Maintains | Overweight |
| 2022-12-05 | Goldman Sachs | Initiate | Sell |
| 2022-11-03 | Oppenheimer | Maintains | Outperform |
| 2022-11-03 | JP Morgan | Maintains | Overweight |
| 2022-11-03 | Morgan Stanley | Maintains | Overweight |
| 2022-11-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-11 | Morgan Stanley | Initiate | Overweight |
| 2022-05-24 | Wedbush | Maintains | Outperform |
| 2022-05-24 | JP Morgan | Maintains | Overweight |